Mental health company atai Life Sciences (NASDAQ: ATAI) was trading more than 31% higher during Tuesday morning’s trading in ...

Sino-American antibody company Adagene (Nasdaq: ADAG) has announced a strategic investment and option exercise by Sanofi ...

A Republican-backed amendment to the sweeping budget proposal championed by US president Donald Trump would sharply reduce ...

Vertex Pharmaceuticals today announced that the European Commission has granted approval for Alyftrek ...

Swedish biotech Camurus (Nasdaq Stockholm: CAMX) has secured EU marketing authorization for its once-monthly acromegaly ...

Marking a new step forward in its international growth, Spanish privately-held pharma company Esteve has entered into an ...

Systemic sclerosis is an autoimmune connective tissue disease that causes debilitating fibrosis of the skin and internal ...

Despite major strides in antiretroviral therapy (ART), the human immunodeficiency virus (HIV) market still faces serious ...

The US Food and Drug Administration (FDA) has issued a complete response letter (CRL) for Unicycive Therapeutics’ New Drug ...

Shares in US biotech INmune Bio slumped by around 60% following news that its Phase II Alzheimer’s study failed to hit its ...

Denmark-based Vesper Bio, a biotech developing an oral therapy for frontotemporal dementia, has announced the appointment of ...

Clinical-stage oncology company Revolution Medicines and fellow USA-based Summit Therapeutics have entered into a clinical ...